Identification of a CTX-M-255 β-lactamase containing a G239S substitution selectively conferring resistance to penicillin/β-lactamase inhibitor combinations

Author:

Andreasen Minna Rud12,Rick Tim3,Alexandersen Nicolai Riff3,Hansen Katrine Hartung24,Pedersen Martin Schou3,Warweitzky Jakob K56,Botelho Carolina Mastella56,Häussler Susanne356ORCID,Jelsbak Lotte1,Schønning Kristian34ORCID

Affiliation:

1. Department of Science and Environment, Roskilde University , Roskilde , Denmark

2. Department of Clinical Microbiology, Copenhagen University Hospital—Amager and Hvidovre , Copenhagen , Denmark

3. Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet , Copenhagen , Denmark

4. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen , Denmark

5. Department Molecular Bacteriology, Helmholtz Centre for Infection Research , Braunschweig , Germany

6. Twincore, Centre for Experimental and Clinical Infection Research, A Joint Venture of the Helmholtz Centre for Infection Research and the Hannover Medical School , Hannover , Germany

Abstract

Abstract Objectives An Escherichia coli isolate, WGS1363, showed resistance to piperacillin/tazobactam but susceptibility to cephalosporins and contained a previously unrecognized β-lactamase, CTX-M-255, as the only acquired β-lactamase. CTX-M-255 was identical to CTX-M-27 except for a G239S substitution. Here, we characterize the hydrolytic spectrum of CTX-M-255 and a previously reported β-lactamase, CTX-M-178, also containing a G239S substitution and compare it to their respective parental enzymes, CTX-M-27 and CTX-M-15. Methods All β-lactamase genes were expressed in E. coli TOP10 and MICs to representative β-lactam-antibiotics were determined. Furthermore, blaCTX-M-15,  blaCTX-M-27, blaCTX-M-178 and blaCTX-M-255 with C-terminal His-tag fusions were affinity purified for enzyme kinetic assays determining Michaelis–Menten kinetic parameters against representative β-lactam-antibiotics and IC50s of clavulanate, sulbactam, tazobactam and avibactam. Results TOP10-transformants expressing blaCTX-M-178 and blaCTX-M-255 showed resistance to penicillin/β-lactamase combinations and susceptibility to cephalothin and cefotaxime in contrast to transformants expressing blaCTX-M-15 and blaCTX-M-27. Determination of enzyme kinetic parameters showed that CTX-M-178 and CTX-M-255 both lacked hydrolytic activity against cephalosporins and showed impaired hydrolytic efficiency against penicillin antibiotics compared to their parental enzymes. Both enzymes appeared more active against piperacillin compared to benzylpenicillin and ampicillin. Compared to their parental enzymes, IC50s of β-lactamase-inhibitors were increased more than 1000-fold for CTX-M-178 and CTX-M-255. Conclusions CTX-M-178 and CTX-M-255, both containing a G239S substitution, conferred resistance to piperacillin/tazobactam and may be characterized as inhibitor-resistant CTX-M β-lactamases. Inhibitor resistance was accompanied by loss of activity against cephalosporins and monobactams. These findings add to the necessary knowledge base for predicting antibiotic susceptibility from genotypic data.

Funder

Novo Nordisk Foundation

Publisher

Oxford University Press (OUP)

Reference19 articles.

1. Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli;Ortega;Antimicrob Agents Chemother,2012

2. Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli;Rodríguez-Villodres;J Antimicrob Chemother,2020

3. Resistance to piperacillin/tazobactam in Escherichia coli resulting from extensive IS26-associated gene amplification of blaTEM-1;Hansen;J Antimicrob Chemother,2019

4. IRT and CMT β-lactamases and inhibitor resistance;Cantón;Clin Microbiol Infect,2008

5. CTX-M-190, a novel β-lactamase resistant to tazobactam and sulbactam, identified in an Escherichia coli clinical isolate;Shen;Antimicrob Agents Chemother,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3